TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.
Location: France, New Aquitaine, Pessac
Total raised: $86.87M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | XAnge Priv... | xange.fr |
| - | AQUITI Ges... | aquiti.fr |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 19.04.2022 | Grant | $100K | - |
| 14.09.2021 | Series B | $75.59M | - |
| 05.09.2019 | Grant | $3.32M | - |
| 13.05.2019 | Series A | $7.86M | - |
Mentions in press and media 22
| Date | Title | Description |
| 29.05.2024 | TREEFROG THERAPEUTICS PICKS-UP BEST POSTER AWARD AT THE INTERNATIONAL SOCIETY FOR CELL & GENE THERAPY (ISCT) ANNUAL MEETING FOR THEIR CELL THERAPY PROGRAM IN PARKINSON'S DISEASE | - Treefrog will present two posters on their cell therapy program in Parkinson's Disease and their proprietary encapsulation technology, C-Stem™ - BORDEAUX, France, May 29, 2024 /PRNewswire/ -- TreeFrog Therapeutics has a busy schedule at t... |
| 20.05.2024 | TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON'S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON | BORDEAUX, France, May 20, 2024 /PRNewswire/ -- TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full m... |
| 23.04.2024 | VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES | Vertex obtains an exclusive license to TreeFrog's C-StemTM manufacturing technology in type 1 diabetes TreeFrog and Vertex to collaborate on scale-up of fully differentiated, insulin-producing pancreatic islet cells BOSTON and BORDEAUX, Fra... |
| 23.04.2024 | VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES | Vertex obtains an exclusive license to TreeFrog's C-StemTM manufacturing technology in type 1 diabetes TreeFrog and Vertex to collaborate on scale-up of fully differentiated, insulin-producing pancreatic islet cells BOSTON and BORDEAUX, Fra... |
| 16.04.2024 | New Drug Shows Promise in Slowing Motor Deterioration Caused by Parkinson's Disease | John Lopez, Tech Times 16 April 2024, 11:04 am A new ray of hope shines for those living with Parkinson's disease (PD), as a groundbreaking drug, Prasinezumab, shows significant promise in slowing motor deterioration associated with the con... |
| 15.04.2024 | TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S CELL THERAPY PROGRAM AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING | TreeFrog Therapeutics reports on the first bioproduction of a cell therapy for Parkinson's Disease in a scalable bioreactor1 BORDEAUX, France, April 15, 2024 /PRNewswire/ -- TreeFrog Therapeutics, a cell therapy development company with its... |
| 21.03.2024 | TreeFrog's Chief Scientific Officer & Co-founder, Maxime Feyeux, to present at The 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM) | - TreeFrog Therapeutics demonstrates fast, sustained, full motor recovery in preclinical models for Parkinson's Disease cell therapy program using C-Stem™ proprietary technology[1] - BORDEAUX, France, March 21, 2024 /PRNewswire/ -- TreeFrog... |
| 05.03.2024 | This Swedish startup wants to reduce the cost, and controversy, around stem cell production | With the news that “mini organs” have been grown for the first time using human stem cells, this futuristic area of bio-medicine is clearly accelerating by leaps and bounds. However, harvesting stem cells is a controversial process, since a... |
| 09.11.2023 | TREEFROG THERAPEUTICS REINFORCES EXECUTIVE COMMITTEE WITH THREE NEW MEMBERS | Jaime Arango, Chief Financial Officer, Jens Schröder as Chief Medical Officer and Rachel Mooney, Chief Communications Officer BORDEAUX, France, Nov. 9, 2023 /PRNewswire/ -- TreeFrog Therapeutics, a global biotechnology company advancing a p... |
| 08.03.2023 | Finding the Fountain of Youth: Meet the Startups Pioneering Longevity Solutions | If technology allowed humanity to live forever in the future, would you take the ticket? We asked our readers recently and were surprised to see the balance tilt towards “No” (60% of respondents). One answer was hidden in a comment from one... |
Show more